Portfolio
Portfolio

enGene

Developing the Gene Pill for oral, local delivery of DNA and RNA to the gut

Oral gene delivery to the gut allows for the treatment of a wide range of diseases. enGene’s lead indications are graft-versus host disease and inflammatory bowel disease, and has strategic partnerships with J&J and Takeda. enGene is based in Montreal with clinical operations in Boston.

  • CEO Anthony Cheung, PhD
  • Industry Biotech